Late recovery of stereotactic radiosurgery induced perilesional edema of an arteriovenous malformation after bevacizumab treatment

References

• Lawton MT, Rutledge WC, Kim H, et al. Brain arteriovenous malformations. Nat Rev Dis Primers 2015;1:15008.
   PubMed Web of Science ®Google Scholar
• Williams BJ, Park DM, Sheehan JP. Bevacizumab used for the treatment of severe, refractory perilesional edema due to an arteriovenous malformation treated with stereotactic radiosurgery. J Neurosurgery 2012;116:972–7.
   PubMed Web of Science ®Google Scholar
• Papavassiliou E, Gogate N, Proescholdt M, et al. Vascular endothelial growth factor expression in injured rat brain. J Neuropathol Exp Neurol 1999;58:613–27.
   PubMedGoogle Scholar
• Chang JH, Chang JW, Choi JY, Park YG, Chung SS. Complications after gamma knife radiosurgery for benign meningiomas. J Neurol Neurosurg Psychiatry 2003;74:226–30.
   PubMed Web of Science ®Google Scholar
• Denizot Y, De Armas R, Caire F, et al. The Quantitative analysis of bFGF and VEGF by ELISA in human meningiomas. Mediators Inflamm 2006;2006:36376.
   PubMed Web of Science ®Google Scholar
• Heiss JD, Papavassiliou E, Merrill MJ, et al. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. J Clin Invest 1996;98:1400–8.
   PubMed Web of Science ®Google Scholar
• Kotsarini C, Griffiths PD, Wilkinson ID, Hoggard N. A systematic review of the literature on the effects of dexamethasone on the brain from in vivo human-based studies: implications for physiological brain imaging of patients with intracranial tumors. Neurosurgery 2010;67:1799–815.
   PubMed Web of Science ®Google Scholar
• Desjardins A, Reardon DA, Coan A, et al. Bevacizumab and daily temozolomide for recurrent glioblastoma. Cancer 2012;118:1302–12.
   PubMed Web of Science ®Google Scholar
• Cai R, Barnett GH, Novak E, Chao ST, Suh JH. Principal Risk of Peritumoral edema after stereotactic radiosurgery for intracranial meningioma is tumor-brain contact interface area. Neurosurgery 2010;66:513–22.
   PubMed Web of Science ®Google Scholar
• Singh VP, Kansal S, Vaishya S, Julka PK, Mehta VS. Early complications following gamma knife surgery for intracranial meningiomas. J Neurosurg 2000;93:57–61.
   PubMed Web of Science ®Google Scholar
• Stafford SL, Pollock BE, Foote RL, et al. Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 2001;49:1029–38.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Kida Y, Mori Y. Long term results of stereotactic gamma radiosurgery of meningiomas. Surg Neurol 2001;55(6):325–31.
   PubMedGoogle Scholar
• Kan P, Liu JK, Wendland MM, Shrieve D, Jensen RL. Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development. J Neurooncol 2007;83:33–8.
   PubMed Web of Science ®Google Scholar
• Otsuka S, Tamiya T, Ono Y, et al. The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J Neurooncol 2004;70:349–57.
   PubMed Web of Science ®Google Scholar
• Gurkanlar D, Er U, Sanli M, Ozkan M, Sekerci Z. Peritumoral brain edema in intracranial meningiomas. J Clin Neurosci 2005;12:750–3.
   PubMed Web of Science ®Google Scholar
• Patil CG, Hoang S, Borchers DJ, et al. Predictors of Peritumoral edema after stereotactic radiosurgery of supratentorial meningiomas. Neurosurgery 2008;63:435–42.
   PubMed Web of Science ®Google Scholar
• Osawa T, Tosaka M, Nagaishi M, Yoshimoto Y. Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema. J Neurooncol 2013;111:49–57.
   PubMed Web of Science ®Google Scholar
• Sheehan JP, Lee CC, Xu Z, Przybylowski CJ, Melmer PD, Schlesinger D. Edema following Gamma Knife radiosurgery for parasagittal and parafalcine meningiomas. JNS 2015;123:1287–93.
   Google Scholar
• Conti A, Pontoriero A, Siddi F, et al. Post-treatment edema after meningioma radiosurgery is a predictable complication. Cureus 2016;8:e605.
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Mathieu D, Lunsford LD, et al. Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery 2008;62:53–60.
   PubMed Web of Science ®Google Scholar
• Giglio P, Gilbert MR. Cerebral radiation necrosis. Neurologist 2003;9:180–8.
   PubMed Web of Science ®Google Scholar
• Rahmathulla G, Recinos PF, Valerio JE, Chao S, Barnett GH. Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review. Stereotact Funct Neurosurg 2012;90:192–200.
   PubMed Web of Science ®Google Scholar
• Bruce JN, Criscuolo GR, Merrill MJ, Moquin RR, Blacklock JB, Oldfield EH. Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone. J Neurosurg 1987;67:880–4.
   PubMed Web of Science ®Google Scholar
• Yoshioka H, Hama S, Taniguchi E, Sugiyama K, Arita K, Kurisu K. Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply. Cancer 1999;85:936–44.
   PubMed Web of Science ®Google Scholar
• Lamszus K, Lengler U, Schmidt NO, Stavrou D, Ergün S, Westphal M. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery 2000;46:938–47. discussion 947–8.
   PubMed Web of Science ®Google Scholar
• Ding YS, Wang HD, Tang K, Hu ZG, Jin W, Yan W. Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas. Ann Clin Lab Sci 2008;38:344–51. PMID: 18988927
   PubMed Web of Science ®Google Scholar
• Sakuma T, Nakagawa T, Ido K, Takeuchi H, Sato K, Kubota T. Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas. J Neurooncol 2008;88:143–55.
   PubMed Web of Science ®Google Scholar
• Levin VA, Bidaut L, Hou P, et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int Radiat Oncol Biol Phys 2011;79:1487–95.
   PubMed Web of Science ®Google Scholar
• Lou E, Sumrall AL, Turner S, et al. Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series. J Neurooncol 2012;109:63–70.
   PubMed Web of Science ®Google Scholar
• Gonzalez J, Kumar A, Conrad C, Levin V. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 2007;67:323–6.
   PubMed Web of Science ®Google Scholar
• Deibert CP, Ahluwalia MS, Sheehan JP, et al. Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery. J Neurooncol 2013;115:217–23.
   PubMed Web of Science ®Google Scholar
• Hatake K, Doi T, Uetake H, Takahashi Y, Ishihara Y, Shirao K. Bevacizumab safety in Japanese patients with colorectal cancer. Jpn J Clin Oncol 2016;46:234–40.
   PubMed Web of Science ®Google Scholar